Nanotechnology enables the detection of biomarkers at very low concentrations, which is crucial for early diagnosis of diseases. The high surface area-to-volume ratio of nanomaterials allows for the immobilization of a large number of biomolecules, enhancing the interaction between the biomarker and the detection platform. This results in improved sensitivity and faster detection times.
